Evidence map›Paper›PMID 33274777›Full record

ArticleAnnals of neurology2021

Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood.

AnnaLynn M Williams, Yin Ting Cheung, Geehong Hyun, Wei Liu, Kirsten K Ness, Matthew J Ehrhardt, Daniel A Mulrooney, Nickhill Bhakta, Pia Banerjee, Tara M Brinkman and 7 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Psychosocial interventions for children and adolescents across the cancer care continuum: A systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Trial
  3. Frailty and neurocognitive impairments in Chinese survivors of childhood cancer.Journal of cancer survivorship : research and practice · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

AnnaLynn M WilliamsDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-7042-5851
Yin Ting CheungSchool of Pharmacy, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Geehong HyunDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Wei LiuDepartment of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA.
Kirsten K NessDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Matthew J EhrhardtDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Daniel A MulrooneyDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Nickhill BhaktaDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Pia BanerjeeDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Tara M BrinkmanDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Daniel M GreenDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Wassim ChemaitillyDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
I-Chan HuangDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Deokumar SrivastavaDepartment of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA.
Melissa M HudsonDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Leslie L RobisonDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
Kevin R KrullDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
St. Jude Children's Research Hospital · USChinese University of Hong Kong · HK

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivorsK00CA222742 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WILLIAMS, ANNALYNN · 2019 to 2020
$180k
NCI NIH HHS K00 CA222742NCI NIH HHS P30 CA021765NCI NIH HHS U01 CA195547
6 · The paper itself

Abstract

objectiveThis study used childhood cancer survivors as a novel model to study whether children who experience central nervous system (CNS) injury are at higher risk for neurocognitive impairment associated with subsequent late onset chronic health conditions (CHCs).

methodsAdult survivors of childhood cancer (n = 2,859, ≥10 years from diagnosis, ≥18 years old) completed a comprehensive neurocognitive battery and clinical examination. Neurocognitive impairment was defined as age-adjusted z score < 10th percentile. Participants impaired on ≥3 tests had global impairment. CHCs were graded using the Common Terminology Criteria for Adverse Events v4.3 (grade 1, mild; 2, moderate; 3, severe/disabling; 4, life-threatening) and were combined into a severity/burden score by frequency and grade (none/low, medium, high, and very high). A total of 1,598 survivors received CNS-directed therapy including cranial radiation, intrathecal methotrexate, or neurosurgery. Logistic regression estimated the odds of neurocognitive impairment associated with severity/burden score and grade 2 to 4 conditions, stratified by CNS treatment.

resultsCNS-treated survivors performed worse than non-CNS-treated survivors on all neurocognitive tests and were more likely to have global neurocognitive impairment (46.9% vs 35.3%, p < 0.001). After adjusting for demographic and treatment factors, there was a dose-response association between severity/burden score and global neurocognitive impairment, but only among CNS-treated survivors (high odds ratio [OR] = 2.24, 95% confidence interval [CI] = 1.42-3.53; very high OR = 4.07, 95% CI = 2.30-7.17). Cardiovascular and pulmonary conditions were associated with processing speed, executive function, and memory impairments in CNS-treated but not non-CNS-treated survivors who were impacted by neurologic conditions.

interpretationReduced cognitive/brain reserve associated with CNS-directed therapy during childhood may make survivors vulnerable to adverse cognitive effects of cardiopulmonary conditions during adulthood. ANN NEUROL 2021;89:534-545.

Indexed as

Cancer SurvivorsAdultAntimetabolites, AntineoplasticCardiovascular DiseasesChronic DiseaseCognitive DysfunctionCranial IrradiationEndocrine System DiseasesHumansInjections, SpinalLogistic ModelsMental Status and Dementia TestsMethotrexateNervous System DiseasesNeurocognitive DisordersNeurosurgical ProceduresAntimetabolites, AntineoplasticMethotrexate

Identifiers

PMID33274777
PMCPMC7897299
OpenAlexW3106743223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.